För att webbplatsen ska fungera på ett bra sätt för dig använder vi nödvändiga kakor. Vi använder också kakor för webbanalys för att förbättra webbplatsen.
Ashina et al, Safety and efficacy of eptinezumab for migraine prevention in patients with two-to-four previous preventive treatment failures (DELIVER): a multi-arm, randomised, double-blind, placebo-controlled, phase 3b trial, Lancet Neurol 2022 Jul;21(7):597-607. doi: 10.1016/S1474-4422(22)00185-5
Aurora et al, Cephalalgia. 2010 Jul;30(7):793-803. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial.
Diener et al, Cephalalgia. 2010 Jul;30(7):804-14. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial.
Jackson et al, PLoS One. 2019 Mar 20;14(3):e0212785 Beta-blockers for the prevention of headache in adults, a systematic review and meta-analysis.
Jackson et al, J Gen Intern Med. 2017 Dec;32(12):1351-1358. Tricyclic and Tetracyclic Antidepressants for the Prevention of Frequent Episodic or Chronic Tension-Type Headache in Adults: A Systematic Review and Meta-Analysis.
Jackson et al, PLoS One. 2015 Jul 14;10(7):e0130733.A Comparative Effectiveness Meta-Analysis of Drugs for the Prophylaxis of Migraine Headache.
Kallen et al, Drug Saf, 2011 vol. 34(8) pp. 691-703 Delivery outcome after maternal use of drugs for migraine: a register study in Sweden
Liampas et al, Findings of systematic review and meta-analysis suggest potential benefit of melatonin in the prevention of migraine in adults Headache 2020 Apr 30
Nezvalova-Henriksen et al, Eur. J. Epidemiol., 2013 vol. 28(9) pp. 759-69 Triptan safety during pregnancy: a Norwegian population registry study
Stovner et al. Cephalalgia 2013; 34: 523–32. A comparative study of candesartan versus propranolol for migraine prophylaxis: A randomised, triple-blind, placebo-controlled, double cross-over study.
Tepper et al, Lancet Neurol. 2017 Jun;16(6):425-434. Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomi- sed, double-blind, placebo-controlled phase 2 trial.
Silberstein et al, N Engl J Med. 2017 Nov 30;377(22):2113-2122. Fremanezumab for the Preventive Treatment of Chronic Migraine.
